Truist Financial’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,839
| Closed | -$201K | – | 2585 |
|
|
2024
Q4 | $201K | Sell |
4,839
-6,646
| -58% | -$276K | ﹤0.01% | 2372 |
|
|
2024
Q3 | $768K | Sell |
11,485
-7,172
| -38% | -$479K | ﹤0.01% | 1651 |
|
|
2024
Q2 | $2.22M | Buy |
18,657
+1,275
| +7% | +$151K | ﹤0.01% | 1215 |
|
|
2024
Q1 | $1.85M | Sell |
17,382
-2,332
| -12% | -$248K | ﹤0.01% | 1317 |
|
|
2023
Q4 | $1.96M | Sell |
19,714
-156
| -0.8% | -$15.5K | ﹤0.01% | 1266 |
|
|
2023
Q3 | $2.05M | Buy |
19,870
+11,718
| +144% | +$1.21M | ﹤0.01% | 1223 |
|
|
2023
Q2 | $990K | Buy |
8,152
+926
| +13% | +$113K | ﹤0.01% | 1586 |
|
|
2023
Q1 | $1.11M | Sell |
7,226
-1,591
| -18% | -$244K | ﹤0.01% | 1499 |
|
|
2022
Q4 | $1.58M | Buy |
8,817
+2,225
| +34% | +$400K | ﹤0.01% | 1315 |
|
|
2022
Q3 | $779K | Buy |
6,592
+306
| +5% | +$36.2K | ﹤0.01% | 1596 |
|
|
2022
Q2 | $899K | Sell |
6,286
-802
| -11% | -$115K | ﹤0.01% | 1601 |
|
|
2022
Q1 | $1.22M | Sell |
7,088
-33,285
| -82% | -$5.73M | ﹤0.01% | 1525 |
|
|
2021
Q4 | $10.3M | Sell |
40,373
-3,731
| -8% | -$948K | 0.02% | 628 |
|
|
2021
Q3 | $17M | Sell |
44,104
-10,738
| -20% | -$4.13M | 0.03% | 459 |
|
|
2021
Q2 | $12.9M | Sell |
54,842
-8,131
| -13% | -$1.91M | 0.02% | 546 |
|
|
2021
Q1 | $8.25M | Buy |
62,973
+13,934
| +28% | +$1.82M | 0.01% | 662 |
|
|
2020
Q4 | $5.12M | Buy |
49,039
+17,927
| +58% | +$1.87M | 0.01% | 802 |
|
|
2020
Q3 | $2.2M | Buy |
31,112
+26,330
| +551% | +$1.86M | ﹤0.01% | 1037 |
|
|
2020
Q2 | $307K | Buy |
+4,782
| New | +$307K | ﹤0.01% | 1922 |
|